Return On Assets of Checkpoint Therapeutics, Inc. from 30 Jun 2017 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Checkpoint Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2017 to 31 Mar 2025.
  • Checkpoint Therapeutics, Inc. Return On Assets for the quarter ending 31 Mar 2025 was -431%, a 43% increase year-over-year.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2024 was -743%, a 22% increase from 2023.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2023 was -950%, a 317% decline from 2022.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2022 was -228%, a 146% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Checkpoint Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -431% +319% +43% 01 Jan 2025 31 Mar 2025
Q4 2024 -743% +207% +22% 01 Oct 2024 31 Dec 2024
Q3 2024 -659% +64% +8.8% 01 Jul 2024 30 Sep 2024
Q2 2024 -673% -196% -41% 01 Apr 2024 30 Jun 2024
Q1 2024 -750% -441% -143% 01 Jan 2024 31 Mar 2024
Q4 2023 -950% -722% -317% 01 Oct 2023 31 Dec 2023
Q3 2023 -723% -535% -286% 01 Jul 2023 30 Sep 2023
Q2 2023 -477% -327% -218% 01 Apr 2023 30 Jun 2023
Q1 2023 -309% -190% -160% 01 Jan 2023 31 Mar 2023
Q4 2022 -228% -135% -146% 01 Oct 2022 31 Dec 2022
Q3 2022 -187% -123% -191% 01 Jul 2022 30 Sep 2022
Q2 2022 -150% -92% -160% 01 Apr 2022 30 Jun 2022
Q1 2022 -119% -57% -91% 01 Jan 2022 31 Mar 2022
Q4 2021 -93% -22% -32% 01 Oct 2021 31 Dec 2021
Q3 2021 -64% +11% +14% 01 Jul 2021 30 Sep 2021
Q2 2021 -58% +43% +43% 01 Apr 2021 30 Jun 2021
Q1 2021 -62% +49% +44% 01 Jan 2021 31 Mar 2021
Q4 2020 -70% +68% +49% 01 Oct 2020 31 Dec 2020
Q3 2020 -75% +83% +53% 01 Jul 2020 30 Sep 2020
Q2 2020 -101% +46% +31% 01 Apr 2020 30 Jun 2020
Q1 2020 -111% +23% +17% 01 Jan 2020 31 Mar 2020
Q4 2019 -138% -18% -15% 01 Oct 2019 31 Dec 2019
Q3 2019 -158% -54% -52% 01 Jul 2019 30 Sep 2019
Q2 2019 -147% -50% -51% 01 Apr 2019 30 Jun 2019
Q1 2019 -134% -38% -39% 01 Jan 2019 31 Mar 2019
Q4 2018 -120% -37% -45% 01 Oct 2018 31 Dec 2018
Q3 2018 -104% -23% -29% 01 Jul 2018 30 Sep 2018
Q2 2018 -97% -27% -38% 01 Apr 2018 30 Jun 2018
Q1 2018 -96% 01 Jan 2018 31 Mar 2018
Q4 2017 -83% 01 Oct 2017 31 Dec 2017
Q3 2017 -81% 01 Jul 2017 30 Sep 2017
Q2 2017 -70% 01 Apr 2017 30 Jun 2017

Checkpoint Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -743% +207% +22% 01 Jan 2024 31 Dec 2024
2023 -950% -722% -317% 01 Jan 2023 31 Dec 2023
2022 -228% -135% -146% 01 Jan 2022 31 Dec 2022
2021 -93% -22% -32% 01 Jan 2021 31 Dec 2021
2020 -70% +68% +49% 01 Jan 2020 31 Dec 2020
2019 -138% -18% -15% 01 Jan 2019 31 Dec 2019
2018 -120% -37% -45% 01 Jan 2018 31 Dec 2018
2017 -83% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.